UV Light Therapy Research for Psoriasis Listed below are just a few of the research studies that have been published in reputable medical journals in relation to UV Therapy for Psoriasis. Links to the summaries of the research papers have been provided. For the full research papers, please go to www.purplehealth.com   SUMMARY Psoriasis is a chronic fluctuating dermatosis with demonstrable impact on patients' quality of life. Our aim was to investigate if narrowband UVB phototherapy administered to psoriatic patients in a standardized manner leads to an improvement in patients' perceived quality of life. A total of 138 patients with psoriasis were recruited from referrals to the Skin and Cancer Foundation, Australia between January 1998 and September 2002. Patients had psoriasis inadequately controlled by topical therapies alone and no contraindications to the use of phototherapy. Patients completed a pre- and post-therapy questionnaire on quality of life parameters. The differences in mean and standard deviation of quality of life parameters were measured using a paired sample t-test based on pre- and post-phototherapy questionnaires. Ninety patients were included in the study. Forty-eight patients were excluded as they had not completed post-phototherapy questionnaires. The course of narrowband UVB phototherapy was found to significantly improve quality of life in psoriasis patients (P <or= 0.005). We conclude that narrowband UVB phototherapy improves quality of life in patients with psoriasis. Australas J Dermatol. 2006 Feb;47(1):37-40 Quality of life in psoriasis improves after standardized administration of narrowband UVB phototherapy. Lim C, Brown P. Click here for more information on this Psoriasis Research UV Therapy     The cost of treating severe psoriasis has risen dramatically, and treatment options vary widely in terms of cost and efficacy. However, little information is available on the relative costs of home phototherapy and other long-term management options, specifically in the context of managed care. A payer-perspective cost model was developed to estimate and compare the direct expenditures associated with a 30-year course of various treatments for severe psoriasis. Within two years of treatment initiation, home-administered ultraviolet B phototherapy was less costly than any of the other treatments examined, including methotrexate, psoralen plus ultraviolet A, the retinoid acitretin, and new biologic agents. In addition, the efficacy and safety profile of home ultraviolet B phototherapy make it an excellent choice for extended management. Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis. Yelverton CB, Kulkarni AS, Balkrishnan R, Feldman SR. Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Click here for more information on this Psoriasis Research UV Therapy     Psoriasis is a common, chronic inflammatory disease that can cause as much disability as cancer, diabetes or other major medical illnesses. Traditional therapies for treating moderate-to-severe psoriasis include phototherapy, methotrexate, oral retinoids and ciclosporin. New biological treatments provide further therapeutic options, but add to the already considerable cost of managing psoriasis. Expert panels have published guidelines for the use of biological agents in managing moderate-to-severe psoriasis; however, few if any of these guidelines appropriately consider the cost-effectiveness of treatment options. When considering cost-effectiveness in addition to safety and efficacy, ultraviolet Type B phototherapy seems to be the best first-line agent for the control of moderate-to-severe psoriasis, despite a small potential for cumulative toxicity. The biologics should be considered as second-line agents alongside the traditional systemic treatments when phototherapy proves to be ineffective or is otherwise contraindicated, such as in patients with psoriatic arthritis. Cost-effectiveness of moderate-to-severe psoriasis treatment.Miller DW, Feldman SR. Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Click here for more information on this Psoriasis Research UV Therapy The UVS Handheld Therapy Lamp can be used alone or in combination with other medications applied directly to the skin. It is very easy and pleasant to use. * Enhances M-Folia - a small study done at a London hospital found that people who did NOT respond to Light Therapy, did respond when using M-Folia in conjunction. > State of the art Photon Therapy > No need for drugs! No need for goggles! > UVS Handheld Therapy Lamp provides a highly effective Psoriasis treatment without the need for photosensitizing drugs > Effective for spot or scalp Psoriasis treatment! > Portable and lightweight - ideal for localized treatment. > Unique design allows precise scalp psoriasis treatment UVS Handheld Therapy Lamp comes with a protected head - safe for the skin. > Shipped fully assembled, so it’s ready for immediate use & we include a spare bulb! Features:       Low power: do not need cooler medium Temperature control: warm and comfortable Light weight: portable, can use at any time, any place Treatment: for psoriasis and a variety of other skin diseases Specification: Power Source : 220 VAC ONLY - suitable for UK, Europe & Australia. If your country has a different power supply, you will need a Transformer & adaptor Power Switch : HIGH/ OFF/ LOW Treatment Area: 18 cm2 Weight: 200 grams Price: £69.95       Order TODAY:  1 2 3 4 " The UV Handheld Therapy Lamp - safe, effective, portable & affordable! TJ approved Your current order shows - Quantity: Total: Total exc Tax: Total Tax: